AffiliationChristie Hospital NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK. Electronic address: email@example.com. Open Patient Data Exploratory Network, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Medicine, Holbæk Hospital, Holbæk, Denmark; NDORMS, University of Oxford, Oxford, UK. Electronic address: firstname.lastname@example.org.
MetadataShow full item record
AbstractHormonal regulation plays a key role in determining bone mass in humans. Both skeletal growth and bone loss in health and disease is critically controlled by endocrine factors and low bone mass is a feature of both excess and deficiency of a broad range of hormones. This article explores the impact of diabetes and thyroid, parathyroid, sex steroid and growth hormone disorders on bone mass and fracture risk. Evidence for current management strategies is provided along with suggested practice points and gaps in knowledge for future research.
CitationHigham C, Abrahamsen B. Regulation of bone mass in endocrine diseases including diabetes. Best Practice & Research Clinical Endocrinology & Metabolism. Elsevier BV; 2022. p. 101614.
JournalBest Pract Res Clin Endocrinol Metab
- Endocrine disorders.
- Authors: Hordon LD, Wright V
- Issue date: 1994 Jan
- [Endocrine disorders and osteoporosis].
- Authors: Kinoshita Y
- Issue date: 2015 Oct
- The skeletal effects of primary hyperparathyroidism.
- Authors: Grey AB
- Issue date: 1997 Apr
- Biochemical bone turnover markers in hormonal disorders in adults: a narrative review.
- Authors: Szulc P
- Issue date: 2020 Oct
- Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.
- Authors: Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, Sosa JA, Sumner AE, Anton B
- Issue date: 2012 Sep